Background A next-generation multitarget stool DNA test, including assessments of DNA
molecular markers and hemoglobin level, was developed to improve the performance of …

Background An accurate, noninvasive test could improve the effectiveness of colorectal-
cancer screening. Methods We compared a noninvasive, multitarget stool DNA test with a …

Background: Colorectal cancer is the second leading cause of malignant death, and better
preventive strategies are needed. Participation rates for colorectal cancer screening remain …

Fecal (or stool) DNA examination is a noninvasive strategy recommended by several
medical professional societies for colorectal cancer (CRC) screening in average-risk …

Objective To assess the accuracy of a multitarget stool DNA test (MT-sDNA) compared with
fecal immunochemical testing for hemoglobin (FIT) for detection of screening-relevant …

METHODS: Whole stool samples (n= 1,047) were prospectively collected and subjected to
an MT-sDNA test, which tests for KRAS mutations, NDRG4 and BMP3 promoter methylation …

Stool DNA testing has evolved into what is now a highly accurate and well-validated test for
the screen detection of colorectal neoplasia. An optimized and automated multi-target stool …

Background: Stool DNA testing is a new approach to colorectal cancer detection. Few data
are available from the screening setting. Objective: To compare stool DNA and fecal blood …

Colorectal cancer is the second-leading cause of cancer death. New noninvasive options for
screening capable of diagnosing cancer at an early stage are needed to improve …

Background & Aims Colorectal cancer (CRC) and advanced precancers can be detected
noninvasively by analyses of exfoliated DNA markers and hemoglobin in stool. Practical and …